EU/EEA Respiratory Virus Network meeting 2024
The EU/EEA Respiratory Virus Network meeting was organised by the European Centre for Disease Prevention and Control between 12 – 14 June 2024 in Stockholm, Sweden. The meeting included discussions on the epidemiology and virology of respiratory viruses and experiences in conducting integrated surveillance of influenza, SARS-CoV-2 and respiratory syncytial virus.
Presentations
Alberto Mateo Urdiales: Using emergency department data for early warning and SARI surveillance in Italy
Anna Maisa: Surveillance of respiratory infections in France 2023-2024
AnnaSara Carnahan: Surveillance of severe influenza and COVID-19 in Sweden
Carlos Carvalho: EHR-based SARI surveillance in the EU/EEA updates and plans for the future
Danija Malceva: Surveillance of influenza and other acute respiratory infections, Latvia
David Kuti: The effects of the COVID-19 pandemic on Hungarian surveillance
Eeva Broberg: EU case definitions for respiratory viruses
Joan O'Donnelll: Surveillance of other respiratory pathogens 2023-2024 winter season, Ireland
Joel Mossong: RSV surveillance in Luxembourg and impact of nirsevimab on hospitalizations during 2023/24 season
Katarina Prosenc Trilar, Anne Teirlinck: Defining RSV qualitative indicators in PROMISE and experiences from their implementation in Slovenia
Laurane De Mot: RESPI-RADAR a Belgian tool to monitor respiratory infections
Lisa Domegan: RSV surveillance in Ireland-preparing for RSV immunisation programmes
Luisa Hallmaier-Wacker, James Fielding: The first season of ERVISS: challenges and lessons learned drafting an integrated summary
Marie-Anne Rameix-Welti: Genotyping and phenotypic testing of RSV
Mariëtte Hooiveld: Pneumonia in children 2023/24
Nick Bundle: Developing integrated respiratory surveillance systems in the EU/EEA -an update
Nick Bundle: EU/EEA level RSV surveillance data and opportunities
Olav Hungnes: How to count weekly infections when patients are tested more than once?
Piers Mook, Luisa Hallmaier-Wacker: Qualitative indicators for surveillance: past, present, and future directions
Ruth Harvey: Virological analyses for influenza virus infections in 2023/2024
Silke Buda: Severe viral respiratory disease surveillance
Silke Buda, Kristin Tolksdorf: Weekly ARI reporting at RKI, Germany
Susana Monge: Estimating effectiveness and impact of nirsevimab using sentinel surveillance data in Spain
